Choose what fits your life
Beyond that, some other potential risks included sleep issues, low blood pressure (sometimes leading to fainting), kidney stones, arthritis, and acute pancreatitis
Not all weight loss peptides use weight-based dosing
Retatrutide appears alongside a other experimental or unapproved compounds: Cagrilintide, Tesamorelin, BPC-157, TB-500, GHK-Cu and injectable NAD+
GLP-1 medications are FDA-approved for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater alongside at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol
Overstated claims tend to travel together